Sarah is a seasoned leader in biotechnology with 20 years of experience developing antibody-based therapeutics for cancer and inflammatory diseases. A Ph. D. graduate from Stanford University, she has expertise in immuno-oncology and has transitioned multiple programs from research to IND filing.
Now semi-retired, Sarah remains deeply engaged with the bioscience community. She actively follows the latest market trends and therapeutic approaches, frequently sharing insights and information about industry events in the Bay Area, such as forums on cancer treatment and protein design.
She co-developed the novel immuno-oncology immunocytokine "Attenukine™" technology, taking it from concept all the way to clinical trials.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.